Importance of the domain-domain interface to the catalytic action of the NO synthase reductase domain by Welland, Andrew et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Importance of the domain-domain interface to the catalytic action
of the NO synthase reductase domain
Citation for published version:
Welland, A, Garnaud, PE, Kitamura, M, Miles, CS & Daff, S 2008, 'Importance of the domain-domain
interface to the catalytic action of the NO synthase reductase domain' Biochemistry, vol. 47, no. 37, pp.
9771-9780. DOI: 10.1021/bi800787m
Digital Object Identifier (DOI):
10.1021/bi800787m
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Peer reviewed version
Published In:
Biochemistry
Publisher Rights Statement:
Copyright © 2008 by the American Chemical Society. All rights reserved.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
 Importance of the Domain-Domain Interface to the Catalytic 
Action of NO Synthase Reductase Domain ** 
Andrew Welland, Pierre E. Garnaud, Maki Kitamura, Caroline S. Miles and Simon Daff*
 
 
EaStCHEM,
 
School of Chemistry, Joseph Black Building, University of Edinburgh, West Mains 
Road, Edinburgh, EH9 3JJ, UK. 
[
*
]
Corresponding author; e-mail: Simon.Daff@ed.ac.uk, tel: +44 (0)131 650 7378 
[
**
]
This work was supported in part by Wellcome Trust grant 066774, by a University Royal Society 
Fellowship to SD, a BBSRC Ph.D. studentship to AW and by a University of Edinburgh, School of 
Chemistry Christina Millar studentship to P.G. who is currently at the Center for Infectious Diseases 
and Vaccinology, Arizona State University. 
Abbreviations: 
nNOSrd, recombinant neuronal nitric oxide synthase reductase domain; nNOS, rat neuronal nitric 
oxide synthase; CPR, mammalian cytochrome P450 reductase; CaM, calmodulin; nNOSFMNCaM, 
the recombinant FMN-binding sub-domain of rat nNOS with bound CaM; EGTA, ethylene 
bis(oxyethylene-nitrilo)tetraacetic acid; DTT, dithiolthreitol; PMSF, phenylmethylsulphonyl fluoride; 
OTTLE, optically transparent thin-layer electrode; SI, small insertion in nNOSrd; AI, autoinhibitory 
insert in nNOSrd; CT, C-terminal extension to nNOSrd. 
 
Graphical abstract: 
 
Keywords: 
Nitric Oxide; Electron Transfer; Kinetics; Salt Bridge   
This document is the Accepted Manuscript version of a Published Work that appeared in 
final form in Biochemistry, copyright © American Chemical Society after peer review and 
technical editing by the publisher. To access the final edited and published work see 
http://dx.doi.org/10.1021/bi800787m 
 
Cite as: 
Welland, A., Garnaud, P. E., Kitamura, M., Miles, C. S., & Daff, S. (2008). Importance of 
the domain-domain interface to the catalytic action of the NO synthase reductase domain. 
Biochemistry, 47(37), 9771-9780. 
 
Manuscript received: 02/05/2008; Revised: 23/07/2008; Article published: 22/08/2008 
Page 1 of 26 
Abstract 
Calmodulin (CaM) activates NO synthase (NOS) by binding to a 20-amino-acid interdomain hinge in 
the presence of Ca
2+
, inducing electrons to be transferred from the FAD to the heme of the enzyme via 
a mobile FMN domain. The activation process is influenced by a number of structural features, 
including an autoinhibitory loop, the C-terminal tail of the enzyme and a number of phosphorylation 
sites. Crystallographic and other recent experimental data imply that the regulatory elements lie 
within the interface between the FAD- and FMN- binding domains, restricting the movement of the 
two cofactors with respect to each other. Arg 1229 of rat neuronal NOS is a conserved residue in the 
FAD domain that forms one of only two electrostatic contacts between the domains. Mutation of this 
residue to Glu reverses its charge and is expected to induce an interdomain repulsion, allowing the 
importance of the interface and domain-domain motion to be probed. The charge-reversal mutation 
R1229E has three dramatic effects on catalysis: (i) Hydride transfer from NADPH to FAD is activated 
in the CaM-free enzyme (ii) FAD to FMN electron transfer is inhibited in both forms and (iii) 
Electron transfer from FMN to the surrogate acceptor cytochrome c is activated in the CaM-free 
enzyme. As a result, during steady-state turnover with cytochrome c, calmodulin now deactivates the 
enzyme and causes cytochrome c-dependent inhibition. Evidently, domain-domain separation is large 
enough in the mutant to accommodate another protein between the cofactors. The effects of this single 
charge-reversal on three distinct catalytic events illustrates how each is differentially dependent on the 
enzyme conformation and supports a model for catalytic motion in which steps (i), (ii) and (iii) occur 
in the hinged open, closed and open states respectively. This model is also likely to apply to related 
enzymes such as cytochrome P450 reductase. 
 
Main text 
Nitric Oxide (NO) fulfils multiple physiological roles, as a signalling agent in neurotransmission and 
vasodilation, and produces reactive oxygen species responsible for the destruction of pathogens by the 
immune system 
[1,2]
. The mammalian NO synthases (NOS) produce NO by the two-step oxidation of 
L-arginine, via N-hydroxy-arginine, to citrulline, utilising two equivalents of molecular oxygen and 
one and a half equivalents of NADPH as substrates 
[3,4]
. 
Of the three NOS isoforms in mammals, endothelial NOS (eNOS) and neuronal NOS (nNOS) are 
expressed constitutively, with their activity being regulated by intracellular Ca
2+
 concentration, via the 
reversible binding of Calmodulin (CaM). The third, inducible NOS (iNOS), binds CaM at low Ca
2+
 
concentrations and is regulated at the transcriptional level 
[4]
. Each isoform is homodimeric, with 
subunits that comprise an N-terminal oxygenase domain linked to a C-terminal reductase domain by a 
CaM binding site (of approximately 20 amino-acids). The reductase domain of one subunit supplies 
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electrons to the oxygenase domain of the other subunit 
[5, 6] 
via a large-scale conformational 
movement, which is integral to the CaM-dependent activation mechanism but is largely undefined. 
The oxygenase domain binds a cysteine-ligated heme, tetrahydrobiopterin (H4B) and L-arginine, 
forming the unique active site where oxygen is bound and NO synthesis takes place 
[7-9]
.  
The reductase domain contains FAD, FMN and NADPH, has a structure analogous to that of 
NADPH-cytochrome P450 reductase (CPR
) [10, 11]
, and can be divided into an N-terminal flavodoxin-
like domain that binds FMN and a C-terminal FAD domain that is similar to ferrodoxin NADP
+
 
reductase (FNR) 
[12]
. Electrons are derived from NADPH dehydrogenation at the FAD and passed 
sequentially through FMN to the heme in the oxygenase domain. The FMN oscillates between the 
semiquinone and hydroquinone states during catalysis, serving as a simple one-electron donor 
[13]
, and 
it is this electron transfer that is both the rate-determining step in NO synthesis and the event activated 
by CaM 
[14]
. 
The isolated reductase domain (nNOSrd) is also activated by the binding of CaM 
[15]
, with the transfer 
of electrons to external electron acceptors such as ferricyanide or cytochrome c and NADPH-
dependent flavin reduction all being accelerated 
[16]
. Given that there is little effect on the reduction 
potentials of the flavins 
[17]
, it has been proposed that a conformational rearrangement in the reductase 
domain induced by the binding of CaM is responsible 
[18, 19]
. 
There are a number of unique structural features involved in suppressing electron transfer through 
CaM-free nNOSrd, including a 42 amino-acid insert in the FMN domain 
[20, 21]
, and a 33 residue 
extension to the C-terminus 
[22, 23]
 that have both been shown to be autoinhibitory domains. Deletion 
of either of these activates electron transfer through the CaM-free reductase domain and synthesis of 
NO in the holoenzyme 
[24]
. It has recently been proposed that the concerted action of these and bound 
Calmodulin are essential for activation 
[25]
. Furthermore, there is a four-to-seven residue insertion in 
the hinge region between the FMN and FAD domains 
[26] 
and phosphorylation sites 
[27, 28]
 that have 
roles in the protection of the CaM-binding linker and in defining the level of Ca
2+
sensitivity of the 
enzyme.  
The binding of NADPH is also important in the Ca
2+
/CaM-dependent regulation of nNOSrd, through 
its interactions with residues Arg1400 
[29] at the 2’-phosphate position, and Phe1395 [30, 31], which -
stacks with the FAD isoalloxazine ring system. When NADPH binds to the CaM-free enzyme, 
electron transfer from the FMN to external electron acceptors is inhibited; this is thought to be caused 
by the reductase domain adopting a compact ‘locked’ conformation in which the FMN is inaccessible 
[32]
.  
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In the absence of sufficient structural information, the precise mechanism by which CaM activates 
NO synthase is unclear. However, it appears that CaM-binding induces freedom of conformational 
motion in the reductase domain, allowing the FMN domain to oscillate between positions in which the 
FMN is located close to the FAD and close to the heme 
[41, 42]
. The fluidity, speed and size of this 
movement are unknown. The various autoinhibitory features appear to stabilise the conformation of 
the protein in which the FMN is close to the FAD, as shown in the crystal structure of nNOSrd (Fig. 
1) 
[11]
.  
This paper addresses the relationship between conformational movement and catalytic action in the 
reductase domain of nNOS by alteration of the interface between the FAD and FMN domains. A 
close-up of the interface (Fig. 1) shows the site of an interaction between Arg1229 on the FAD 
domain and an acidic patch on the FMN domain consisting of Glu762, Glu816 and Glu819. This is 
one of only two electrostatic contacts between the domains. The arginine residue is conserved in CPR 
[10]
 but only interacts with a solitary glutamic acid. In order to destabilise the interface in nNOSrd we 
mutated Arg1229 to Glu, reversing its charge and introducing a probable electrostatic repulsion. 
Kinetic analysis of the mutant shows profound changes to several individual catalytic events, which 
are interpreted in terms of the above model.  
 
 
 
Figure 1. Structure of nNOSrd (PDB code 1TLL), showing the FAD-binding domain in red, the 
FMN-binding domain in blue, bound FAD and FMN in yellow and NADPH in grey. Right-hand side: 
Close-up of the interface between the FAD- and FMN- binding domains, with residues Arg1229, 
Glu762, Glu816, Glu819 in stick conformation. 
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Experimental procedures 
Materials: All reagents were purchased from Sigma Aldrich Ltd, unless otherwise stated. 
Generation of the nNOS R1229E mutant: The R1229E mutation was generated in both full-length 
rat nNOS and nNOSrd using the Stratagene QuikChange® XL site-directed mutagenesis kit. The 
templates for the reaction were the nNOS pCWori construct 
[33] 
and pCRNNR 
[34]
, respectively. The 
primers used were R1229EFor (5’GTCCCCTGCTTCGTGGAAGGTGCCCCTAGCTTC) and 
R1229ERev (5’GAAGCTAGGGGCACCTTCCACGAAGCAGGGGAC) which substitute Arg1229 
with glutamic acid. Mismatches are underlined. Products containing the required mutation were 
selected by automated sequencing. Further sequencing confirmed that no secondary mutations were 
present. The resulting plasmids pCM199 and pCM226 (containing the R1229E nNOSrd and R1229E 
nNOS, respectively) were then transferred to E. coli BL21(DE3) for expressing the mutant enzymes. 
pGroESL 
[35]
, which expresses chaperone proteins, was co-transformed into the E. coli strain with the 
full-length nNOS mutant. 
Preparation of wild-type and R1229E nNOSrd, R1229E nNOS, and Calmodulin: Purification of 
wild-type and mutant nNOSrd was carried out using 2’,5-ADP-agarose (1x20cm) and CaM-agarose 
(1x10cm), as previously described 
[32] 
with the additional use of Protease Inhibitor Cocktail at the cell 
lysis stage. In order to keep the bound FMN in the semiquinone form, all buffers were degassed with 
nitrogen prior to use. Enzyme concentration was calculated using an extinction coefficient of 20940 
M
-1
cm
-1 [36]
. CaM was purified using the established protocol 
[32]
.  
R1229E nNOS was purified using 50mM Tris-HCl, pH 7.5, 0.1M KCl, 10% glycerol, 1mM DTT 
(Buffer A), with the addition of 3 EDTA-free Protease Inhibitor tablets, 1mM PMSF and 4mM H4B 
before sonication on ice. The lysate was centrifuged at 48500g for 1 hour and the supernatant passed 
through a DEAE column (2x5cm) and eluted with A. CaCl2 was added to 5mM followed by loading 
onto a CaM-agarose (1x10cm) column before washing with A + 1mM CaCl2 and elution with A + 
5mM EGTA.  Wild-type nNOS was generated in the same manner. 
The isolated FMN domain of rat nNOS (nNOSFMNCaM) was coexpressed and copurified with 
bound calmodulin using anion exchange chromatography as described previously 
[36]
. This mutant 
consists of residues 695-946 and was always handled in the presence of 1 mM Ca
2+
 to ensure bound 
CaM and to maintain stability. Reduced nNOSFMNCaM was prepared in an anaerobic chamber by 
reduction using sodium dithionite followed by G25 gel filtration chromatography.  
Steady-state turnover: The activity of nNOSrd was characterised by the reduction of electron 
acceptors cytochrome c (from Horse Heart) and potassium ferricyanide (FSA Lab supplies) using a 
Cary 50 UV/Vis or Shimadzu UV-1601 spectrophotometer. Assays were carried out at 25
o
C as 
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described previously 
[21]
 and initiated by the addition of enzyme (10-40 nM), NADPH (1 mM) and 
either EGTA (1 mM) or Ca
2+
/CaM (1 mM / 100 M). All experiments were performed in 50mM Tris-
HCl, pH 7.5, 0.1M NaCl. Extinction coefficients used were 21 mM
-1 
cm
-1
 for the difference in molar 
absorbance for reduced and oxidized cytochrome c at 550 nm; 1.01 mM
-1 
cm
-1
 for oxidized 
ferricyanide at 401 nm; 6.22 mM
-1
 cm
-1
 for NADPH at 340 nm. 
Flavin Reduction Kinetics: Pre steady-state reduction of the bound flavins of nNOSrd was carried out 
by stopped-flow (Applied Photophysics) mixing of 10M enzyme with 100M NADPH, in the 
presence or absence of Ca
2+
/CaM. The change in absorbance at 457nm was monitored and the 
resultant traces fitted using Origin 7.0 (Microcal). Full spectra were recorded using a diode-array 
detector, at 2.5 ms intervals. The enzyme was either one-electron reduced by titration against 
dithionite in an anaerobic glove box (Belle Technology), or fully oxidised by addition of excess 
potassium ferricyanide followed by size exclusion chromatography (Sephadex G-25). 
In the case of inhibition studies, 30M of ferrous cytochrome c was added to the enzyme before 
mixing. This was prepared by titration with sodium dithionite and removal of excess reductant by size 
exclusion chromatography (Sephadex G-25). 
Cytochrome c reduction: Stopped-flow cytochrome c reduction experiments were carried out as 
previously reported 
[32]
, 4M of cytochrome c was mixed with 10M sodium dithionite-reduced 
nNOSrd in the presence and absence of CaM and the presence and absence of NADPH. Substrate 
(cytochrome c) inhibition studies were also conducted in the presence of 30M ferrous cytochrome c. 
Reduction was observed at 550nm, and pseudo-first order rate constants were calculated by fitting the 
resultant traces to single exponential functions. Second order rate constants were determined by 
dividing the pseudo-first order constants by the enzyme concentration. The second order behaviour of 
this reaction was confirmed for R1229E nNOSrd by varying the concentration of enzyme in the 
reaction from 7 to 15 M. The rate constant increased linearly with concentration and had a second 
order constant of 39 mM
-1
s
-1
 as for the wild-type enzyme 
[32]
. 
Spectroelectrochemistry: Spectroelectrochemical analysis of nNOSrd was carried out using 
approximately 0.2 mM enzyme in an OTTTLE cell of 0.2 mm path length as previously described 
[36]
, 
with the addition of the mediators FMN (15M), benzyl viologen (20M), methyl viologen (30M), 
2-hydroxy-1,4-naphthoquinone (30M) and 5-hydroxy-1,4-naphthoquinone (30M). The Ag/AgCl 
reference electrode was calibrated against indigotrisulfonic acid and FMN and found to be +205 ± 
2mV relative to the standard hydrogen electrode (SHE). All electrode potentials were corrected 
accordingly. 
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UV-Visible spectra were collected at 30mV intervals in the reductive and oxidative directions, and the 
absorbance at 456 nm and 540 nm plotted vs applied potential. Both sets of data were fitted 
simultaneously to a double Nernst-type equation (equation 3) using Origin 7.5 (Microcal). The 
equation has three parameters: a, b and c representing the absorption coefficients of the flavin 
oxidized, semiquinone and reduced states respectively. These are allowed to vary at each different 
wavelength, whereas the 4 reduction potential values are the same at both wavelengths. The FMN and 
FAD are assumed to have the same extinction coefficients in their respective redox states, which is a 
good approximation for the wavelengths used according to parameters derived from the single 
domains 
[36]
. No additional constraints were imposed on the fitting process and convergence was 
achieved from any reasonable estimate of the parameters prior to fitting. R
2
 = 0.99692 and 0.99748 
for the wild-type and R1229E data respectively. 
NO synthesis: Full-length nNOS was assayed for NOS activity by monitoring the conversion of 
oxyhemoglobin to methemoglobin at 401 nm, using an extinction co-efficient of 49000 M
-1
cm
-1
. The 
reaction was started when nNOS (~20nM) was added to a cuvette containing 10µM oxyhemoglobin, 
100µM NADPH, 10units/ml Superoxide dismutase (SoD) and catalase, 10µM H4B, 0.1mM DTT, 
1mM L-Arg, 50g/ml CaM, 1mM CaCl2 and made up to 1 ml with Tris-HCl (50 mM, pH 7.5) buffer. 
NADPH oxidation rates were also collected by monitoring at 340 nm in the absence of 
oxyhemoglobin, extinction co-efficient 6220 M
-1
cm
-1
. 
 
Results 
Steady-state turnover: Cytochrome c reduction by nNOS is activated by CaM binding, this effect has 
been shown to be reproduced in nNOSrd. Rate constants for the steady-state reduction of cytochrome 
c by wild-type nNOSrd are plotted in Fig. 2A and fitted to the Michaelis-Menten equation. The 
kinetic parameters are given in Table 1. The kcat for cytochrome c reduction is enhanced 10-fold upon 
binding of CaM, as shown previously 
[16]
. Fig. 2B plots the data obtained from the steady-state 
reduction of cytochrome c by R1229E nNOSrd. In the CaM-free assay, the rate initially increases with 
the concentration of cytochrome c, to a maximum of 7.5 s
-1
; however it then decreases at 
concentrations greater than 20M. This indicates that excess cytochrome c is inhibiting catalytic 
turnover. When CaM is present the rate of cytochrome c reduction is much lower (< 2 s
-1
), and 
inhibition is apparent at cytochrome c concentrations as low as 2M. The CaM-free data fit well to a 
model for substrate inhibition in which the substrate (cytochrome c) binds to an unproductive form of 
the enzyme (Equation 1). Inhibition occurs with the CaM-bound mutant even at low concentrations of 
cytochrome c, so these data are fitted to a simpler inhibition equation (Equation 2). The difficulty in 
obtaining accurate rate constants at low concentrations of cytochrome c compromises the accuracy of 
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these data. It is also impossible to obtain a Km value. The value for kmin is the estimated rate constant 
for steady-state turnover at high cytochrome c concentration (0.9 ± s
-1
) and kmax is the rate constant 
estimated with no inhibition (i.e. the y-axis intercept). Note that the latter value is likely to be 
underestimated by the fact that decreasing cytochrome c concentrations will cause the observed 
turnover rate to decrease as the Km is approached. However it is clear that the rate of reduction is 
markedly slower for R1229E nNOSrd when CaM is bound, an occurrence not seen in other reductase 
domain mutants, although this is likely to be influenced by the inhibition effect. The overall effect of 
the mutation on the observed rate of cytochrome c reduction by the CaM-bound enzyme is 
particularly large; a decrease from 100 s
-1
 to around 2 s
-1
. The mutation therefore appears to induce 
two separate effects. It decreases the rate of electron transfer through the CaM-bound enzyme and 
introduces substrate inhibition at high cytochrome c concentrations. Both of these may be due to 
changes in the electrostatic interactions within the domain interface. 
 
 
Equation 1. Dependence of rate constant for steady-state turnover on substrate concentration (S) with 
substrate inhibition (Ki).  
 
 
Equation 2. Dependence of rate constant for steady-state turnover on substrate concentration (S) with 
partial substrate inhibition (Ki) for S >> Km. 
 
In order to test this theory, the assay was repeated at varying levels of ionic strength, i.e. increased 
NaCl concentration in the assay buffer. Fig. 2C shows a linear dependence of the log of the rate 
constant for cytochrome c reduction at 15M versus the square root of ionic strength. According to 
Debye-Huckel theory, the primary kinetic salt effect obtained from the gradient of the plot gives the 
ionic charge interaction involved. For both the CaM-free and CaM-bound mutant there is a net unit 
charge interaction of 1. It seems likely therefore that the high salt concentrations can compensate for 
the negative-negative repulsion across the domain-domain interface caused by the mutated residue 
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and increase the rate of interflavin electron transfer. As expected, the electrostatic component of the 
interaction is unaltered by the binding of CaM.   
When the salt concentration was increased to 1M (Fig. 2D), the steady-state kinetic data for R1229E 
nNOSrd fitted to the Michaelis-Menten equation, giving catalytic turnover rates of 25 s
-1 
(CaM-free) 
and 9 s
-1
 (CaM-bound). It is interesting to note that the activity of the enzyme is still decreased by 
more than 2-fold upon binding of CaM, which is opposite to the effect seen in the wild-type enzyme. 
 
 
Figure 2. Steady-state cytochrome c reduction. (A) Wild-type data fitted to the Michaelis-Menten 
equation. (B) R1229E under standard assay conditions, with CaM-free data fitted to Eqn 1 and CaM-
bound data fitted to Eqn 2. (C) R1229E assayed with 15M cytochrome c and increasing 
concentrations of NaCl. The linear relationship, fitted according to Debye-Huckel theory, has a 
gradient of 1 in both cases. (D) R1229E assayed in 1M NaCl buffer and shown fitted to the Michaelis-
Menten equation. All plots show assays performed in the absence (closed circles) and presence (open 
circles) of CaM at 25 °C, as described in experimental procedures. All derived parameters are listed in 
Table 1.  
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The rate of cytochrome c reduction was measured at 25
o
C as detailed in Experimental Procedures and 
plotted in Fig. 2.  
†
 should be considered a lower estimate, given that the Km could not be obtained. 
Table 1. Steady state turnover of cytochrome c 
 
Flavin Reduction Kinetics: The first step in the turnover of nNOSrd is hydride transfer from NADPH 
to bound FAD and can be investigated by the stopped-flow mixing of nNOSrd with an excess of 
NADPH 
[32]
. In these experiments, the enzyme may react further depending on the oxidation state of 
the FMN; if oxidised, the bound FMN can accept 2 electrons from FAD and allow the FAD to react 
with a second molecule of NADPH (Scheme 1). During catalysis however, the FMN is bound as an 
air-stable semiquinone. This form of nNOSrd reacts with NADPH to cause the enzyme to be 3-
electron reduced (Scheme 1). Note that electron transfer from FAD to FMN in this state causes little 
change to the visible spectrum. In order for further reduction of the flavins to occur, intermolecular 
electron transfer must occur between different enzyme molecules, this is known to occur through 
disproportionation, probably via the more accessible FMN cofactor 
[32, 36]
.  
Data for the reduction of one-electron reduced nNOSrd are shown in Figs. 3A and 3B. The kinetic 
traces at 457 nm were fitted to double-exponential fitting functions and the derived parameters listed 
in Table 2. CaM-free wild-type nNOSrd is reduced by NADPH in a biphasic process with a large 
slow phase of rate constant 6.5 s
-1
. The reduction process observed is undoubtedly hydride transfer 
from NADPH to FAD, however it is unclear why this is biphasic. The results are consistent across 
numerous enzyme samples and it is likely that heterogeneity within the sample causes some 
molecules to react faster than others. CaM-bound wild-type nNOSrd is rapidly reduced by hydride 
transfer from NADPH at around 100s
-1
. This is then followed by further slow reduction initiated by 
intermolecular electron transfer and disproportionation of flavin semiquinones, this contributes 
Enzyme CaM kcat (s
-1
) Km (M) Ki (M) 
wild-type - 10.4 ± 0.4 3 ± 1  
 + 104 ± 6 8 ± 2  
wild-type + high 
salt buffer 
- 23 ± 1 12 ± 2  
 + 95 ± 6 12 ± 3  
R1229E - 14.8 ± 1.8 10 ± 2 44 ±9 
 + 3.4 ± 1.8 
†
 - 2 ± 2 
R1229E + high salt 
buffer 
- 24.3 ± 1.4 14 ±2  
 + 8.8 ± 0.5 5 ± 1  
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approximately 20 % of the absorbance change at 457 nm. R1229E nNOSrd exhibits no significant 
dependence on the presence of CaM. As with the CaM-bound wild-type enzyme, hydride transfer 
from NADPH to FAD occurs rapidly and is followed by a slow disproportionation phase of similar 
magnitude. The disproportionation phase can also be observed from the decrease in absorbance at 600 
nm (Fig. 3A) 
[32]
.  
It appears that the rate of reduction of FAD by NADPH is faster in CaM-bound nNOSrd than CaM-
free and that the R1229E mutant is reduced at least as quickly as the CaM-bound enzyme, regardless 
of whether CaM is present or not. The mutation therefore appears to increase the rate of FAD 
reduction by NADPH in the CaM-free enzyme.  
Reduction of fully oxidised nNOSrd is complicated by the reaction of the enzyme sequentially with 
two equivalents of NADPH. Thus hydride transfer from NADPH to FAD is followed by two electron 
transfers from FAD to FMN before the FAD can react with a second molecule of NADPH (Scheme 
1). Kinetic data for the reduction of fully oxidised WT nNOSrd and the R1229E mutant are included 
in Figs. 3C and 3D. As before, the kinetic traces at 457 nm were fitted to double-exponential fitting 
functions and the derived parameters listed in Table 2. From Fig. 3D it is clear that once again CaM-
bound wild-type nNOSrd is reduced more quickly than CaM-free. However, the rate-constants shown 
in Table 2 indicate that there is a shift in amplitude for the fast phase from 40 % to 79 % on the 
addition of CaM rather than an increase in the rate-constant. As with the one-electron reduced 
enzyme, this indicates that some molecules in the CaM-free sample react faster with NADPH than 
others. Previous analyses of similar data have failed to reach a satisfactory explanation for the 
different phases in this reaction 
[18, 31, 32, 43, 44]
 and further studies are necessary to explain the full effect 
of CaM-binding on the NO synthase reductase domain. 
For the R1229E mutant, the data are very different and easier to interpret. The kinetic trace in Fig. 3D 
shows a very rapid first phase, followed by a very slow second phase; a pronounced phase-change is 
apparent. Both phases contribute 50 % of the absorbance change, (Table 2) indicating that half of the 
flavins in the sample are reduced in each phase. In order to gain further insight, the absorbance 
changes at 592 nm should also be considered (Fig. 4), which report on the formation and loss of flavin 
semiquinone species during the reduction process. For the CaM-free wild-type enzyme, a rapid 
increase in semiquinone content is observed, followed by a decrease (Fig 4A). This is consistent with 
the transfer of one electron from FAD to FMN (causing the increase) followed by the transfer of a 
second electron (causing the decrease) as in Scheme 1. For the CaM-bound enzyme the two transfers 
are faster (Fig. 4B), leading to a very transient accumulation of semiquinone. The slow increase 
observed over 4 s is caused by disproportionation of flavins to thermodynamic equilibrium. For the 
R1229E mutant, the initial build up of semiquinone is much slower than for either CaM-free or CaM-
bound wild-type enzyme (Fig 4C), as is the subsequent decay at 592 nm. A larger amount of 
Page 11 of 26 
semiquinone also accumulates. The 592 nm data is shown fitted to a kinetic model for two sequential 
steps, both with rate constants of 10 ± 5 s
-1
, i.e. much slower than the rate of NADPH to FAD hydride 
transfer, but corresponding to the rate of the second phase of reduction at 457 nm (approximately 5 s
-1
 
for the 2-electron transfer). The electron transfers from FAD to FMN appear therefore to have been 
dramatically slowed by the mutation, particularly with respect to the CaM-bound wild-type enzyme. It 
is now clear that the two phases observed in the reduction trace at 457 nm for the R1229E mutant 
represent the sequential reduction of the FAD and FMN cofactors by two equivalents of NADPH. For 
the one-electron reduced mutant enzyme, NADPH to FAD hydride transfer has been shown to occur 
rapidly and completely, whereas for the oxidised enzyme, interflavin electron transfer slows down the 
reaction with the second equivalent of NADPH and is rate-limiting for this step. 
All flavin reduction experiments with the R1229E mutant were repeated in the presence of ferrous 
cytochrome c, but the hydride transfer step did not appear to be affected (data not shown).  
 
 
 
 
Scheme 1. Sequential reduction of fully oxidized and one-electron reduced forms of nNOSrd by 
excess NADPH. 
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Figure 3. Pre-steady state reduction of nNOSrd by NADPH. (A) UV/visible spectra of reaction with 
one-electron reduced R1229E nNOSrd, (B) Kinetic traces at 457 nm for one-electron reduced CaM-
free and bound wild-type nNOSrd and the R1229E mutant. (C) UV/visible spectra of reaction with 
fully oxidised R1229E nNOSrd. (D) Kinetic traces at 457 nm for fully oxidised CaM-free and bound 
wild-type nNOSrd and the R1229E mutant. Enzyme samples were approximately 6 M and NADPH, 
100 M after mixing. All traces were fitted to a double-exponential equation over 1 second. The 
kinetic parameters are listed in Table 2. 
 
wild-type - FMN semiquinone - 35 ± 1 
(20 %) 
6.5 ± 0.1 
(80 %) 
 + 93 ± 2 
(80 %) 
5.1 ± 0.1 
(20 %) 
R1229E – FMN semiquinone - 138 ± 3 
(73 %) 
5.6 ± 0.1 
(27 %) 
 + 162 ± 4 
(80 %) 
4.3 ± 0.1 
(20 %) 
Enzyme Ca
2+
/CaM k1 
(Abs) 
k2 
(Abs) 
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Table 2. Rate-constants for pre-steady-state flavin reduction by excess NADPH. 
 
The rate of flavin reduction was measured at 25
o
C as detailed in Experimental Procedures and plotted 
in Fig 3. Abs values indicate the proportion of the total absorbance change occurring in each kinetic 
phase. 
 
 
Figure 4. Pre-steady state reduction of fully oxidised nNOSrd by NADPH. Time dependent traces for 
the absorbance associated with the FMN semiquinone at 592 nm. (A) Wild-type CaM-free, (B) wild-
type CaM-bound and (C) R1229E CaM-free. Traces are derived from the same experiments as Fig 
3D. 
wild-type – FMN oxidised - 65 ± 2 
 (40 %) 
5.9 ± 0.1  
(60 %) 
 + 73 ± 2 
 (79 %) 
3.6 ± 0.1  
(21 %) 
R1229E - FMN oxidised - 169 ± 5 
 (52 %) 
4.0 ± 0.1  
(48 %) 
 + 156 ± 6  
(57 %) 
5.6 ± 0.1 
(43 %) 
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Cytochrome c reduction: The transfer of an electron from hydroquinone FMN to cytochrome c is the 
final step in the turnover of nNOSrd, and provides an estimate of the accessibility of the bound FMN. 
It can be measured by the stopped-flow mixing of chemically reduced enzyme with a sub-
stoichiometric amount of cytochrome c, in the presence and absence of Calmodulin and NADPH. 
This experiment has previously been used to reveal that the CaM-free NADPH-bound wild-type 
enzyme is in a locked FMN-inaccessible conformation, where the binding of NADPH causes the 
second-order rate-constant to drop from 15M-1s-1 to 1M-1s-1, while the binding of CaM enhances it 
to >35M-1s-1, releasing the lock and allowing the rapid transfer of an electron from FMN to 
cytochrome c 
[32]
. 
Fig. 5 compares traces for pre-steady-state cytochrome c reduction by wild-type nNOSrd with and 
without bound CaM, the R1229E mutant and the isolated nNOS FMN domain under the same 
conditions. For R1229E nNOSrd in the presence or absence of NADPH and CaM, the second-order 
rate-constant was 39 M-1s-1, showing that the bound FMN is always accessible to cytochrome c. The 
presence of NADPH and absence of CaM is unable to induce a locked conformation in the mutant, 
consistent with the theory that the mutation has destabilised the domain-domain interface. Both CaM-
bound wild-type and the R1229E mutant appear to have the similar FMN accessibility to the isolated 
FMN domain, indicating that in both cases the FMN is fully exposed.  
Addition of an excess of ferrous cytochrome c to the enzyme had no effect on the ability of the ferric 
cytochrome c to access the bound FMN (data not shown). 
 
 
Figure 5. Pre-steady state reduction of cytochrome c by reduced nNOSrd. Normalised kinetic traces 
showing the 2
nd
-order reduction of cytochrome c (~4M) by wild-type and R1229E nNOSrd and 
CaM-bound nNOS FMN domain. All enzyme concentrations were 10 M after mixing.  
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Spectroelectrochemistry: Potentiometric studies of nNOSrd have previously shown that the FAD is 
reduced in two one-electron steps of similar potential (approximately -300 mV) and that the FMN is 
reduced in two one-electron steps with very different potentials (approximately -300 mV and -100 
mV) 
[17,36]
. The FMN semiquinone is thermodynamically stabilised towards oxidation (Table 3). It 
also has considerable kinetic stability enabling the FMN to retain the semiquinone oxidation state 
during purification. Similar reduction potentials are observed in the presence and absence of CaM and 
even in the isolated FAD and FMN domains. The exception to this is that the FMN semiquinone loses 
some thermodynamic stability in the isolated domain and shifts to a lower potential. Given that the 
FMN does not cycle through the semiquinone-oxidised redox couple during catalysis, this is not 
functionally important. However, it does indicate that the presence of the FAD domain does affect the 
properties of the FMN.  
R1229E nNOSrd was analysed under the same conditions using OTTLE potentiometry. Fig. 6A 
shows the UV-Visible spectra produced by the stepwise reduction of the mutant by increments of 
30mV. The resultant plot of the absorbance at both 457nm and 540nm versus the applied potential 
(Fig. 6B) was fitted using Equation 3, simultaneously fitting both sets of data, and yielding the 
midpoint reduction potentials given in Table 3. From these, it can be seen that the only potential 
affected by the mutation is the oxidised/semiquinone couple of FMN. The semiquinone form appears 
to have been thermodynamically destabilised relative to the wild-type reductase domain by 
approximately 30 mV. It is interesting that a point mutation in the FAD domain affects only the FMN. 
This is an indication that the interaction between the two sub-domains is important for the stability of 
the semiquinone form of bound FMN and is consistent with the effect observed in the isolated FMN 
domain of a 74 mV shift relative to nNOSrd.  
The potentiometric titration of CaM-free wild-type nNOSrd was also repeated using the OTTLE 
method (Fig. 7). Previously, this was conducted by chemical reduction 
[17]
. The results are very similar 
to those reported earlier, although equilibration of this enzyme was particularly slow, requiring 2 
hours for each potential step. No evidence for CaM-dependent nNOSrd reduction potentials as 
reported recently 
[37]
 could be found.  
 
Page 16 of 26 
 
 
 
Equation 3. Modified Nernst Equation for a system consisting of 2 independent redox centres with 
two 1-electron transitions with midpoint potentials E1, E2 and E3, E4 respectively. Spectral absorption 
coefficients are given by a, b and c for the oxidized, 1-electron reduced and 2-electron reduced redox 
centres respectively. 
 
← Figure 6. Potentiometric titration 
of R1229E nNOSrd. (A) UV-visible 
spectra collected during OTTLE 
titration of R1229E nNOSrd in the 
absence of CaM. (B) Absorbance at 
456nm (circles) and 540 nm (half-
closed circles, x 5) plotted against 
applied potential. The data were 
fitted simultaneously to Eqn 3, 
yielding the mid-point reduction 
potentials listed in Table 3. 
Figure 7.→ Potentiometric titration of 
WT nNOSrd. (A) UV-visible spectra 
collected during OTTLE titration of 
nNOSrd in the absence of CaM. (B) 
Absorbance at 456nm (circles) and 
540 nm (half-closed circles, x 5) 
plotted against applied potential. The 
data were fitted simultaneously to Eqn 
3, yielding the mid-point reduction 
potentials listed in Table 3. 
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Table 3. Midpoint reduction potentials of nNOSrd. 
 
Wild type and R1229E nNOSrd were analysed using OTTLE potentiometry as detailed in 
Experimental Procedures and plotted in Figs 6 and 7. Values for the absorbance parameters were, for 
WT nNOSrd: a456 = 0.055 ; b456 = 0.029; c456 = 0.009; a540 = 0.024 ; b540 = 0.073; c540 = 0.019. For the 
R1229E mutant: a456 = 0.037; b456 = 0.021; c456 = 0.002; a540 = 0.007; b540 = 0.043; c540 = 0.013. 
NO synthesis: Full-length nNOS, both wild-type and R1229E mutant, were assayed for NOS activity. 
There was no CaM-free activity observed for R1229E nNOS, and the CaM-bound activity was 
approximately 5-fold lower than for the wild-type enzyme. NADPH consumption was decreased by 
approximately 2.5-fold. Electron flow through the mutant has been destabilised by the mutation, 
probably resulting in slower flavin to heme electron transfer. Similar studies have been reported for 
mutations at the same interface in full-length nNOS 
[38]
. 
 
Discussion 
Calmodulin (CaM) regulates nNOS by inducing electron transfer through to the heme of the enzyme. 
The mechanism of activation is centered on the reductase domain, which undergoes a structural 
rearrangement on binding CaM, the nature of which is uncertain. In the presence of calcium 
[3, 4]
, CaM 
binds to a flexible loop of protein connecting the oxygenase and reductase domains together. 
Although the structure of the holoenzyme is not known, it is likely that a large-scale motion of the 
FMN-binding domain is required to induce electron transfer to the heme 
[18, 19]
.  
A number of unusual protein inserts not found in the related enzyme, cytochrome P450 reductase, are 
known to influence the activation process; these include an autoinhibitory loop 
[20, 21]
, a C-terminal 
extension 
[22, 23]
, a small insertion 
[26]
, and residues that are targeted for kinase-dependent 
phosphorylation 
[27, 28]
. Alteration of any of these regulatory features activates electron transfer 
through the CaM-free reductase domain, as measured by the reduction of cytochrome c, but not 
necessarily to the NOS oxygenase domain. Table 4 summarises previous data on the activation of 
steady-state cytochrome c reduction by CaM in NOS mutants. The mutations do not generally 
Enzyme FMN ox/sq FMN sq/hq FAD ox/sq FAD sq/hq 
Wild-type ( - CaM) -105 ± 6 -274 ± 7 -283 ± 8 -310 ± 7 
R1229E ( - CaM) -136 ± 6 -279 ± 9 -281 ± 9 -306 ± 9 
Isolated domains 
[36]
 -179 ± 3 -314 ± 3 -291 ± 3 -326 ± 3 
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deactivate turnover in the presence of CaM, indicating that the NOS reductase domain is catalytically 
repressed in the absence of CaM; although deletion of the C-terminal extension produces an enzyme 
that turns over slightly faster in the presence of CaM 
[22]
. This and mutation of Phe1395 
[31]
, which 
facilitates the reaction between NADPH and FAD, both also activate NO synthesis in the CaM-free 
state. The effect of the R1229E mutation on steady-state cytochrome c reduction by nNOSrd is 
particularly severe. In the presence of CaM, the enzyme is 30-fold slower than the wild-type and 4-
fold slower than in the absence of CaM. This unique shift in behaviour is particularly striking given 
that only a single charge reversal mutation is involved and appears to be caused by two factors, 
disruption of FAD to FMN electron transfer and inhibition of this by the electron acceptor cytochrome 
c.  
Arg1229 can be seen in the structure of nNOSrd 
[11] 
and in Fig. 1 to interact with a patch of acidic 
residues on the surface of the FMN domain. Both points of contact are close to the cofactors FMN and 
FAD (approx. 7 Å) and are likely to be a major factor in holding the cofactors so close together (the 
FMN and FAD ring systems are separated by only 6 Å). The contact is conserved in cytochrome P450 
reductase 
[12]
, suggesting that it functions to orient the two domains effectively for interflavin electron 
transfer.  
It is apparent from the crystal structure of nNOSrd (11) that the autoinhibitory elements involved in 
repression of the enzyme lie at the interface between the FAD- and FMN- binding domains. It has 
been speculated that they stabilise a conformation of the CaM-free enzyme in which the FMN is 
“locked” into a solvent-inaccessible position [25, 29]. This form is also stabilised by the binding of 
NADPH and is thought to be represented in the crystal structure 
[11, 32]
. All of the mutations listed in 
Table 4 have multiple effects on the CaM-free enzyme, often characterised by increased cytochrome c 
reductase activity, faster rates of flavin reduction and decreased response to CaM. It is likely that 
destabilisation of the FAD-FMN domain interface is a common cause of these effects. Arg1229 is not 
part of an autoinhibitory feature, or of any other catalytic unit. Therefore, its mutation reports directly 
on the importance of the interface to the different steps of catalysis. 
The catalytic action of nNOSrd involves three primary events: Hydride transfer to FAD, Electron 
transfer from FAD to FMN and Electron transfer from FMN to heme or surrogate electron acceptor. 
Each has been proposed to be activated by CaM 
[14, 16, 18, 32]
. Given the putative role of the 
autoinhibitory inserts in stabilising the domain-domain interface, and of CaM in counteracting the 
effect, it seems likely that CaM may affect all three of the steps simultaneously. If the multiple effects 
of CaM result from destabilisation of the interface, then the R1229E mutation should induce similar 
properties. This is the case for hydride transfer from NADPH to FAD and electron transfer to 
cytochrome c; however the mutation does not activate NO synthesis, which appears to require an 
additional CaM-dependent structural change not involving the interface directly. The effect on FAD 
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to FMN electron transfer is, on the other hand, more dramatic in the mutant, with little observed effect 
in the wild-type enzyme on CaM binding  
Hydride Transfer: The first chemical step of NO synthesis is the transfer of a hydride from NADPH 
to FAD. This is most easily monitored by stopped-flow reaction of enzyme with an excess of 
NADPH. The decrease in the main peak at 456 nm (Fig. 3) reports primarily on flavin reduction 
originating from hydride transfer to the FAD. As the data in Fig. 3B confirm, CaM increases the rate 
of hydride transfer in fully oxidised wild-type nNOSrd, although the actual rate constants determined 
from fitting the data show a shift in the amplitudes from the slow to the fast kinetic phases rather than 
a large change in the rate constants (Table 2). Note also that two consecutive reactions with NADPH 
occur with this enzyme form. For the R1229E mutant the results are more obvious, with two 
exponentials of equal amplitude, it is clear that the first hydride transfer is fast and the second is slow. 
The reason for this is a slow interflavin electron transfer step occurring between the two hydride 
transfers. Note that it is apparent from Fig.3B that removing CaM from nNOSrd and introducing the 
R1229E mutation clearly influence different steps of the reduction process. 
Further insight is gained from considering hydride transfer to the one-electron reduced enzyme by 
NADPH. This is the natural reaction of the enzyme and should only report on a single hydride 
transfer, with subsequent disproportionation of the flavin semiquinones occurring in a slow phase. For 
the wild-type enzyme, hydride transfer is generally slow (6.5 s
-1
 for the large phase) in the absence of 
CaM, and fast (93 s
-1) with CaM bound. Presumably the R1229E mutant favours a “hinged open” 
conformation in which hydride transfer is rapid and interflavin electron transfer is slowed. It is logical 
to consider that the converse is also true, i.e. that hydride transfer in the “hinged closed” or “locked” 
conformation is slowed and interflavin electron transfer is rapid (The two flavin rings are only 6 Å 
apart in the hinged closed state presented in the crystal structure and the NADP is bound in an 
unproductive conformation). This point is worthy of further investigation in the wild-type enzyme and 
may be fundamental to the mechanism of CaM-dependent enzyme activation. If the stability of the 
domain-domain interface determines the rate of hydride transfer from NADPH to FAD by controlling 
the rate at which the enzyme can hinge open (approx. 6.5 s
-1
 CaM-free), then the rate of electron 
transfer from FAD to FMN in the R1229E mutant conversely depends on the rate at which the 
enzyme can hinge closed (approx. 10 s
-1
), if it can access this state at all. The values in Table 2 
indicate that the rate constants for both hydride and interflavin electron transfer increase by at least an 
order of magnitude when the appropriate conformation is stabilised. 
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CT deletion 
[22]
 130 % 
a
the kcat value + CaM is affected by cyt c inhibition and this value is therefore an overestimate. 
Table 4. CaM-dependence of steady-state cytochrome c reduction by nNOSrd and mutants. 
 
Interflavin electron transfer: The fact that cytochrome c is able to inhibit interflavin electron transfer 
in the mutant enzyme suggests that the FAD and FMN domains separate enough to allow another 
protein to access the interface. This indicates that the FMN domain is able to move a large distance 
during catalysis, which may be a feature of electron transfer to the NOS heme in the holoenzyme. In 
fact, the short-range nature of electrostatic interactions such as the salt-bridge between R1229 and the 
acidic patch in nNOS means that once the contact is broken during domain-domain motion, wide 
separation such as that observed in the R1229E mutant is likely. The pre-steady-state reduction of 
cytochrome c by nNOSrd is a second order process dependent on the collision frequency between 
cytochrome c and the FMN. The rate constants measured for CaM-bound wild-type nNOSrd, the 
R1229E mutant and the isolated FMN domain are all very similar, indicating that the FMN is equally 
accessible in all three cases. This indicates that CaM binding induces a mainly open form of the 
enzyme, in which the FMN and FAD are not usually in contact. Electron transfer from FAD to FMN 
in the hinged-closed form is likely to be very rapid over the 6 Å distance reported in the crystal 
structure, such that the hinge closed form may only need to be sampled briefly to maintain turnover. 
Mutation of the acidic patch interface residues Glu816 and Glu762 (and R1229) has recently been 
shown to activate electron transfer through CaM-free nNOS and to slow the rate of electron transfer to 
nNOS heme 
[38]
. It has been speculated that the same residues interact with a basic patch on the 
oxygenase domain, including Lys423. Mutation of this residue has also been shown to affect the rate 
of NO synthesis 
[39]
. None of these mutations, or the R1229E mutant described here, result in the 
activation of NO synthesis in CaM-free nNOS. Thus, there is no direct correlation between the 
strength of interaction across the FMN-FAD domain interface and NO synthesis activity, although 
 kcat (CaM-free) / kcat (CaM-bound) 
Wild-type 10 % 
SI deletion 
[26]
 25 % 
AI deletion 
[21]
 40 % 
R1400E 
[29]
 70 % 
F1395S 
[31]
 85 % 
R1229E 435 %
a
  
R1229E + 1M KCl 275 % 
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there is a relationship. It is interesting that the R1229E mutant, which appears to be forced into an 
open conformation, with little prospect of forming a stable flavin-flavin contact, is still affected by 
CaM-binding in the steady-state cytochrome c reduction assays. CaM-binding appears to enable the 
enzyme to open further, causing increased cytochrome c-dependent inhibition. Thus, in addition to 
releasing the “conformational lock” exhibited by nNOS reductase domain, CaM also appears to 
remove a “hinge stop”, which prevents the two domains from swinging further apart. Such large-scale 
motion may be necessary for the FMN to deliver an electron to the heme. Various candidates for this 
structural feature are the autoinhibitory elements mentioned previously. 
In summary, the R1229E mutation disrupts the FAD-FMN domain interface in nNOSrd such that 
there is no regulatory interaction between the two domains. Electron transfer from FAD to FMN is 
severely retarded and hydride transfer from NADPH to FAD is accelerated, particularly when 
compared to the CaM-free wild-type enzyme. This is consistent with a model for the catalytic action 
of the enzyme in which it exists in two conformational states, “closed” and “open”, with distinct 
kinetic events happening in each state (Fig. 8). The “closed” form allows electron transfer from FAD 
to FMN, while the enzyme must be in the “open” form for both facile hydride transfer from NADPH 
to FAD and electron transfer from FMN to cytochrome c or nNOS heme. The presence of the salt-
bridge at Arginine1229 is clearly essential for the successful movement of the FMN binding domain 
from an electron-receiving position to an electron-donating one and can be thought of as another 
regulatory feature in the complex structural makeup of nNOS. 
 
Figure 8. Cartoon showing how the “hinged open” and “closed” conformations of nNOSrd are 
influenced by CaM binding and the R1229E mutation.
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